Skip to content

Association Between Different Parameters of Nutritional Assessment and Clinical Outcomes in Cancer Patients

Association Between Different Parameters of Nutritional Assessment and Clinical Outcomes in Cancer Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02901132
Enrollment
120
Registered
2016-09-15
Start date
2013-03-31
Completion date
2017-05-31
Last updated
2017-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Postoperative Complications, Sarcopenia

Brief summary

Malnutrition in oncologic patients has a negative impact on post- surgical recovery, survival and quality of life. The etiology of malnutrition in cancer patients is multifactorial, therefore, the nutritional assessment should be carried out by different parameters. The objective of this study is to investigate the association and prognostic value of five distinct methods of nutritional assessment (molecular, body composition, functional, anthropometric and subjective) in relation to postoperative complications and short-term survival in patients with cancer. Regarding the molecular parameter, mtor signaling pathwayon will be assessed in rectus muscle samples, harvested in the moment of the operation. Body composition was assessed by computed tomography (CT) and bioelectrical impedance test was conducted to evaluate the phase angle. Handgrip strength was used to determine functionality. The percentage of weight loss in relation to usual weight was the anthropometric parameter used. Subjective Global Assessment (SGA) was used to provide the nutritional diagnosis. Postoperative complications were classified according to the Dindo and Clavien classification. Overall time survival was the period between the first assessment of the patients until death or end of follow-up. Chi-square test, t test, Kaplan-Meier method and the Log Rank test and regression analysis will be used (p \<0.05).

Interventions

None listed

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnostic cancer confirmed * Over 18 years old * Accepted the terms of survey

Exclusion criteria

* Tumor synchronic * Inflamattory disease * Under 18 years old * No accepted the terms of survey

Design outcomes

Primary

MeasureTime frameDescription
Postoperative complicationsAugust, 2016According to the Dindo-Clavien protocol

Secondary

MeasureTime frameDescription
SurvivalJuly, 2016Follow up using medical records and telephone contacts

Other

MeasureTime frameDescription
mtor signaling pathwayDecember, 2016mTOR Elisa kits

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026